Ruben A. Mesa, MD

Today I join >600 Physicians & Scientists & thousands of team members of @WakeCancer & @LevineCancer joined as one @theNCI Comprehensive Cancer Center - world class cancer care, research & training decreasing cancer burden in the Carolinas & beyond @AtriumHealth @AtriumHealthWFB

Honored to Have Participated in the Meeting of the National Cancer Institute - Ruben Mesa, MD @mpdrc oncodaily.com/voices/ruben-m… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

Ruben Mesa, MD Joins North Carolina Cancer Leaders at ACS CAN Research Symposium @mpdrc oncodaily.com/voices/ruben-m… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

Congratulations to @LeoraBoussi of @MSKCancerCenter on winning the Ruben Mesa,MD Clinical Research Award & @Ruwan_Gunaratne of @Stanford on winning the Ronald Hoffman, MD Translational Research Award @ 4th Myeloid Malignancy @mpn_consortium and #MSSM @TheElfLab

Prevention, Partnership and High-Quality Skin Cancer Care - Ruben Mesa, MD @mpdrc oncodaily.com/voices/ruben-m… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

Happening next: How is first‑line standard of care in myeloid malignancies shifting as we head into 2026? Get the inside track from the experts shaping what’s next. At #NashvilleHeme26, moderator @mpdrc leads a powerhouse panel featuring @GabyHobbs, Anthony Hunter, John Mascarenhas, and @sk_tantravahi—breaking down what community providers need to know now. na2.hubs.ly/H03YqhJ0

Reminder: Applications for #MMW2026 trainee & young investigator awards close February 6. Don’t miss the opportunity for research awards, travel support & presentation opportunities at the 4th Annual Myeloid Malignancy Workshop! 📍 NYC | March 6, 2026 🔗 MMW2026.com

#5thMPNS 🌍📓 MPN Journal, a free & anonymous tool created by patients and supported by Prof. Ruben Mesa (@mpdrc), shows how daily tracking can improve care, conversations & research in MPNs. 🎥 Full video: #viewer-exzwy25527" target="_blank" rel="nofollow noopener">gmpnsf.org/post/one-mpn-f…  #MPNsm

Being prepared for bad weather is important for everyone, but people with cancer also need to plan for potential disruptions to their #CancerCare. If you are in the path of the winter storm, emergency resources are available here: cancer.gov/contact/emerge…

🎥 In a recent interview, @mpdrc of @AtriumHealthWFB provides guidance on selecting between JAK inhibitors for the management of patients with #myelofibrosis. Click here to watch: 👉 ow.ly/zPeQ50Y0zRu 👈 #MPNsm #HemOnc

Michael Chan Appointed Chair of Radiation Oncology at Wake Forest - Ruben Mesa (@mpdrc) oncodaily.com/voices/446357 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

@AshleySumrallMD @NRGonc @Waymo So fun and you can pick your music!

I came to San Fran for @NRGonc #NRG2026 but the main event was my 1st @Waymo ride!! 😱 #imnotdead

A Powerful Call to Build Community and Hope for AYAs in 2026 - Sigrun Hallmeyer oncodaily.com/voices/sigrun-… #Health #Oncology #OncoDaily #Medicine #Cancer @CancerWorldmag

⚠ #ESHMPN2026: 10 DAYS LEFT TO SUBMIT YOUR ABSTRACT! Don’t delay, proceed now ➡ bit.ly/4litFm1 11th Translational Research Conference Myeloproliferative Neoplasms Chairs: @jjkiladjian @rosslevinemd @MullallyLab @jyoti_nangalia April 24-26/Estoril #ESHCONFERENCES #MPNsm

#MMW2026 offers competitive Trainee & Young Investigator Awards: • Two $25,000 research grants awarded • Travel + oral presentations for top awardees and select additional applicants ⏰ Apply by Feb 6 🔗 Apply now: bit.ly/TraineeAwardsM…

Today we’re excited to announce that the US FDA has accepted our sBLA for ropeginterferon alfa-2b-njft for the treatment of patients with essential thrombocythemia (ET), with a PDUFA target action date of August 30, 2026. Press Release: us.pharmaessentia.com/fda-confirms-a…

2026 Cancer Research Retreat at Atrium Health Wake Forest Baptist (@AtriumHealthWFB) - @mpdrc oncodaily.com/voices/ruben-m… #Cancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag

🗓️#ESHCMLMPN2027 SAVE THE DATE: March 5-7, 2027! We are pleased to announce the 5th edition of the ESH How to Diagnose and Treat CML/MPN, in Prague, Czech Republic! Chairs: @harrisoncn1, @AndreasHochhaus, Ruben Mesa @mpdrc ➡ bit.ly/3Z8y3tI #ESHCONFERENCES #MPNsm #CMLsm

A new era in MPN therapy is here. 🚀 Replay now available with Prof. Serge Verstovsek + Prof. Ruben Mesa (@mpdrc) sharing key updates and what’s next in targeted treatments. 🎥 Watch: gmpnsf.org/post/exclusive… #ASH2025 #MPNsm

It's always fantastic to catch up with @mpdrc to hear the latest in the MPN field!🩸 At #ASH25, Dr Mesa shared several updates, including results of the IMPRSSION trial, which evaluated the TMPRSS6 antisense inhibitor sapablursen for #PolycythemiaVera. Watch here: 🎥 ow.ly/YXtu50XTWUS #MPNsm #CTSM #TrialUpdate #HemOnc

Cutting Edge Cancer Research Facilities at @wakeforestmed - @mpdrc oncodaily.com/voices/ruben-m… #Cancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag